Navigation Links
World BioBank(TM) Launch Benefits Advanced Medical Research
Date:4/22/2009

Human Tissue Collection and Specimen Management Provide Focus

MEMPHIS, Tenn., April 22 /PRNewswire/ -- World BioBank(TM), founded by the physician partners of Accelerated Community Oncology Research Network, Inc. (ACORN) and based in Memphis, TN (USA), has begun acquiring human tissue samples for scientific research. In addition to tissue collection, World BioBank supports biomarker storage in conjunction with clinical trial operations and provides biomarker consultation services. Specimen storage management services include inventory tracking, processing, storage and shipment. "World BioBank opens the opportunity for patient-specific, targeted therapies and as such heralds a new era of scientific commitment to research and personalized patient care," announced Lee S. Schwartzberg, MD, FACP, President of ACORN.

One of World BioBank's distinguishing features is its commitment to marry samples to a wealth of longitudinal medical data and tissue-specific data, including both pathology data and quality measures that are often very difficult to obtain. "With a strong commitment to the advancement of bioscience, World BioBank operates with an eye toward the improvement of patient outcomes. Patient well-being along with vigilance toward privacy and security directs operational decisions," added Edward J. Stepanski, PhD, COO, ACORN.

World BioBank(TM) collects cancer samples, normal samples, and other non-neoplastic diseases. Standardized intake, processing and release procedures assure the highest quality samples and data. Sample types routinely collected and housed include: solid tissues (snap frozen and matched formalin-fixed paraffin embedded diseased and normal internal controls) from surgical resections, image-guided biopsies, bone marrow biopsies and endoscopic biopsies. Liquid samples are obtained from peripheral blood, genomic DNA (from buffy coat), and plasma. Drawn from a demographically rich universe, these annotated samples offer the added information advantage of pathology, clinical and outcomes data.

Demanding SOPs help ensure high quality biospecimens. Rapid turn-around techniques ensure that both liquid and solid samples are verified and preserved within minutes of excision or draw.

Tyron (Ty) Hoover, MD, JD, serves as Executive Director of World BioBank(TM). Dr. Hoover brings special expertise to biobanking and Medico-legal issues including Informed Consent, Privacy, Bioethics. Upon completing a Pathology Residency at Baylor University Medical Center, Dr. Hoover's interest in the legal aspects of medicine led him to attain his JD, Southern Methodist University Dedman School of Law, Dallas, TX. He practiced law in Florida before serving as the Medical Director of the Biospecimen Repository and Total Cancer Care at the H. Lee Moffitt Cancer Center & Research Institute. He also co-directed the University of South Florida College of Medicine's Scholarly Concentration in Law & Medicine.

"By collecting and storing tissue and data from thousands of patients, World BioBank hopes to make a significant contribution to the fight against cancer and other diseases by providing greatly needed materials for scientists and doctors to study," remarked Dr. Hoover during World BioBank's opening. Samples will be available for both academic and private medical research.

Sample collection has begun at West Clinic, Memphis, TN. The multidisciplinary practice has over 110,000 patient encounters annually, with the potential of over 30,000 unique samples for the biorepository. "Memphis is a particularly important collection site as it offers a diverse demographic population. Other venues will be added as the year progresses," explained Dr. Schwartzberg. Cj Finke serves as Project Manager for World BioBank and handles sponsor needs for specimen management and sample requests.

For additional information visit www.WorldBioBank.net

About World BioBank (www.WorldBioBank.net)

Founded by the physician partners of ACORN (Accelerated Community Oncology Research Network), World BioBank embraces forward-thinking technology and a strong commitment to the advancement of bioscience. World BioBank provides industry and academia genetically diverse, high quality, standardized biospecimens with high quality data. Services also include biomarker storage, management and consultation for clinical trials and other scientific study.


'/>"/>
SOURCE World BioBank
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. GlaxoSmithKline and Stiefel to Create New World-Leading Specialist Dermatology Business
2. IVF Baby Born From 21-Year-Old Frozen Sperm, Ties World Record
3. Ansell Healthcare Espresses Firm Commitment to Support Continued Education of Healthcare Professionals Worldwide
4. Elsevier and Brain Mapping Foundation Co-Host 6th Annual World Congress of IBMISPS on Brain Mapping and Image Guided Therapy
5. NexGen Biofuels Ltd Signs Letter of Intent for the Purchase of World Venture Management, Inc. Assets and the Sale of its Current Business
6. Heart Hospital of Austin First Site in World to Test Efficacy of New Adult Stem Cell Therapy to Treat Damaged Heart Tissue in Phase II Trial
7. Health Care Innovations and Opportunities Attract Attendees from 40 Countries and Delegations from 12 to 6th Annual World Health Care Congress
8. Keynote Panel at Bio-IT World Expo to Feature Five Leaders in the Field of "Personal Genomics"
9. VisualSonics to Sell Mauna Kea Technologies Cellvizio(R) LAB on a Worldwide Basis to Animal Imaging Market
10. TechConnect World Announces The CancerNano 2009 Symposium May 3-7, at the George R. Brown Convention Center in Houston
11. Cepheid Announces New Diagnostic Technology to Aid World Efforts in Halting the Spread of Mycobacterium Tuberculosis (TB)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... , March 24, 2017  Infectex Ltd., a ... today announced positive results of a Phase 2b-3 clinical ... regimen in patients with multidrug-resistant pulmonary tuberculosis (MDR-TB). SQ109 ... at Sequella, Inc. ( USA ) and ... A total of 140 patients were enrolled in a ...
(Date:3/24/2017)... March 24, 2017 Agenus Inc. (NASDAQ: AGEN), ... antibodies and cancer vaccines, today announced participation at the ...  Annual William Blair and Maidstone Life Sciences conference "Cancer ... in New York, NY . Agenus ... 29 at 9:40 am: Robert B. Stein , ...
(Date:3/23/2017)... , March 23, 2017  SeraCare ... to global in vitro diagnostics manufacturers and ... the industry,s first multiplexed Inherited Cancer ... testing by next-generation sequencing (NGS). The Seraseq™ ... developed with input from industry experts to ...
(Date:3/23/2017)... NetworkNewsWire Editorial Coverage  ... Cancer remains one of the world,s ... systems, in terms of costs and resources. However, as the ... of innovative and efficient therapies that demonstrate higher chances of ... cancer treatments, a growing number of patients receiving immuno-oncology therapies ...
Breaking Biology Technology:
(Date:2/24/2017)... -- EyeLock LLC, a leader of iris-based identity authentication ... solution on the latest Qualcomm® Snapdragon™ 835 mobile ... Congress 2017 (February 27 – March 2, ... Stand 3E10. The Snapdragon 835 ... combination of hardware, software and biometrics technologies ...
(Date:2/21/2017)... , February 21, 2017 ... 70 Millionen US-Dollar wachsen. Nach einem Gespräch mit mehr als ... einige Hindernisse zu überwinden gilt, um diese Prognose zu ... ... anderem die Mobilisierung der finanziellen Mittel für die Biobank, ...
(Date:2/13/2017)... FRANCISCO , Feb. 13, 2017  RSA ... centralized platform that is designed to enhance fraud ... latest release in the RSA Fraud & Risk ... enable organizations to leverage additional insights from internal ... tools to better protect their customers from targeted ...
Breaking Biology News(10 mins):